Market Growth The Harmony Prenatal Test offers a non-invasive, highly accurate prenatal screening solution that reduces the need for invasive procedures. With growing demand for accessible NIPT, sales opportunities exist to expand adoption through OB/GYN practices, maternal-fetal medicine clinics, and hospital laboratories, and to pursue payer coverage strategies that broaden patient access.

Partner Network The company sits among potential enterprise partners in the prenatal testing landscape, with peers like Natera, Myriad Genetics, and Quest Diagnostics. Opportunities include engaging these labs as distributors, co-development partners, or contract testing providers to extend Harmony’s reach, including international markets where these players already operate.

IP Collaboration The patent litigation activity related to fetal DNA extraction methods highlights IP risk in cfDNA testing. This creates openings for licensing discussions, partnerships with IP holders, or assurances of IP clarity to customers, helping differentiate offerings and reduce client risk.

Tech Integration Existing tech stack shows Windows Server and Microsoft IIS, suggesting a sales angle around lab IT integration. Propose enabling seamless LIMS and EHR integrations, HL7/FHIR data exchange, and HIPAA-compliant cloud or on-premises data management to streamline ordering, reporting, and analytics for hospital networks.

Growth Readiness With mid-sized scale, a Roche acquisition history, and a revenue range indicative of growth potential, there are opportunities for strategic partnerships, licensing, or co-development with larger diagnostics players and distributors to accelerate geographic expansion and product reach.